**Specifications table**TableSubject areaEnvironment and healthMore specific subject areaEnvironmental pollution, cytogenetic alterationType of dataTable and figureHow data was acquiredCA and CBMN were acquired using ZEISS MetaSystems (Germany). DNA damage was detected by comet assay.Data formatAnalyzedExperimental factorsSemen and blood were sampled from the two groups in our lab.Experimental featuresLymphocytes were cultured in RPMI 1640 medium for CA and CBMN assay. Spermatozoa or lymphocytes were suspended in PBS for comet assay.Data source locationInstitute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical CollegeData accessibilityAll the data are in this data article.

**Value of the data**.

The data were helpful to understand the positive associations between both CA and CBMN and the duration of working with e-wastes.

When stratified for age, for each of the age sub-groups, a statistically significant difference was observed between the group exposed to e-waste and the reference group.

Semen quality was worse in the workers who recycled e-wastes than that of reference subjects.

1. Data {#s0005}
=======

A largest electronic waste disposal centers in northern China had been found recently years. Components of e-wastes such as electronic circuit boards or microchips were illegally burned or heated for reclaimable materials ([Fig. 1](#f0005){ref-type="fig"}).Fig. 1Recycling of e-wastes without any protection. Heat the circuit boards to get metals.Fig. 1

The exposure and reference group were both divided by age into three sub-groups (20--29, 30--39 and \>40 years old). For each age sub-group, significant differences were found between exposure and reference groups ([Fig. 2](#f0010){ref-type="fig"}A-F). No significant difference was observed among age-groups in either the exposure or reference group ([Fig. 2](#f0010){ref-type="fig"}A-F).Fig. 2DNA damage detected by comet assay in lymphocytes and spermatozoa for different age sub-groups. The group of workers recycling e-wastes and reference group were both divided into three sub-groups by age (20--29, 30--39 and \>40 years old). A-C: TDNA%, TM and OTM in lymphocytes between the group of workers recycling e-wastes and reference group for the sub-groups divided by age. D-F: TDNA%, TM and OTM in spermatozoa between the group of workers recycling e-wastes and reference group for the sub-groups divided by age. \*\*: *P* \< 0.01. Two way ANOVA was also used to test the interactions between age and DNA damage in lymphocytes and spermatozoa, respectively. (lymphocytes: *F* = 2.13, *P* = 0.15; spermatozoa: *F* = 1.67, *P* = 0.21).Fig. 2

The exposure group was stratified into three sub-groups according to their exposure time (≤ 3, 3--6 and \> 6-year groups). The statistical significant relationships between DNA damage (TDNA%, TM) and duration of exposure for DNA damage were found in both lymphocytes and spermatozoa ([Fig. 3](#f0015){ref-type="fig"}A and B).Fig. 3Relationship between exposure duration and DNA damage of lymphocytes (A) and spermatozoa (B) in the exposed group. It showed significant relationship between TDNA%, TM and exposure duration for not only lymphocytes but also spermatozoa. \*: *P* \< 0.05.Fig. 3

For each of the sub-groups divided by age, there was significantly higher of CA and CBMN in the e-waste workers compared to the reference group ([Fig. 4](#f0020){ref-type="fig"}A and B). No significant difference was found among sub-groups in either the exposure or reference group ([Fig. 4](#f0020){ref-type="fig"}A and B).Fig. 4CA (A) and CBMN (B) in lymphocytes of workers recycling e-wastes and in reference group for different age sub-groups. A-B: CA and CBMN in lymphocytes between the group of workers recycling e-wastes and reference group for the sub-groups divided by age. There is no difference of CA and CBMN among the age sub-groups. \*\*: *P* \< 0.01. Two way ANOVA was also used to test the interactions between age and CA, CBMN in lymphocytes, respectively. (CA: *F* = 2.03, *P* = 0.18; CBMN: *F* = 1.07, *P* = 0.39).Fig. 4

Statistically significant was found between CA, CBMN and exposure time ([Fig. 5](#f0025){ref-type="fig"}A). A classical micronucleus in a binucleated lymphocyte, a dicentric chromosome and an acentric fragment are shown in [Fig. 5](#f0025){ref-type="fig"}B and C.Fig. 5Relationship between exposure duration and frequency of CA and CBMN in lymphocytes of exposed subjects. A: It shows significant relationships between CA, CBMN and exposure duration in lymphocytes. B: One micronucleus in a binucleated lymphocyte of the group of workers recycling e-wastes. C: A metaphase lymphocyte of the group of workers recycling e-wastes. The red arrow directs a dicentric chromosome; the blue arrow directs an acentric fragment. \*\*: *P* \< 0.01, \*: *P* \< 0.05.Fig. 5

Sperm motility rate, abnormality rate and total sperm counts were analyzed in the three sub-groups divided by age for exposure and reference groups. For the same age sub-groups, significant difference was found between exposure and reference group ([Fig. 6](#f0030){ref-type="fig"}A, B and C). The sperm parameters above also showed significant difference among different sub-groups in exposure or reference group respectively ([Fig. 6](#f0030){ref-type="fig"}A1, B1 and C1).Fig. 6Sperm motility rate, abnormality rate and total sperm counts for different age sub-groups. A-C: Sperm motility rate, abnormality rate and total sperm counts between the group of workers recycling e-wastes and reference group for the sub-groups divided by age. There is significant difference of sperm motility rate, abnormality rate and total sperm counts between the group of workers recycling e-wastes and reference group in the age sub-groups, respectively. A1-C1: Line chart showed the change of sperm motility rate, abnormality rate and total sperm counts along with age. There is significant difference of sperm motility rate, abnormality rate and total sperm counts among the age sub-groups in exposure or reference group respectively. \*\*: *P* \< 0.01, \*: *P* \< 0.05. Two way ANOVA was also used to test the interactions between age and sperm motility rate, abnormality rate and total sperm counts, respectively. (sperm motility rate: *F* = 3.24, *P* = 0.07; abnormality rate: *F* = 3.13, *P* = 0.08; total counts: *F* = 2.89, *P* = 0.12).Fig. 6

Relationship between semen alteration and exposure time of e-wastes was analyzed in exposure group. For the three sub-groups divided by exposure time (≤ 3, 3--6 and \>6years groups), semen parameters were analyzed for every two sub-groups by Wilcoxon rank-sum test. Sperm motility rate, semen volume, sperm concentration and total sperm count decreased significantly with exposure time, however, sperm abnormality rate increased significantly with e-wastes exposure time ([Fig. 7](#f0035){ref-type="fig"}).Fig. 7Relationship among semen parameters and exposure duration. A: Sperm motility rate and semen volume decreased but sperm abnormality rate increased significantly with e-wastes exposure duration. B: Sperm concentration and total sperm count both decreased significantly with exposure duration. \*: *P* \< 0.05.Fig. 7

RNA of peripheral blood cells was isolated by use of the RNeasy Mini kit (Qiagen, Hilden, Germany) as instructed by the manufacturer. Integrity of RNA was assessed by means of the Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA). 84 key genes ([Table 1](#t0005){ref-type="table"}) from Human DNA Damage Signaling Pathway were simultaneously assayed by use of the RT2Profiler PCR array plate (SuperArray Bioscience Corporation, Frederick, MD) according to the manufacturer\'s protocol. The detail of gene expression analysis was shown in Ref. [@bib1].Table 1Gene table of the 84 genes assayed with Human DNA Damage Signaling pathway PCR array RT2Profiler.Table 1**No.UnigeneGeneBankSymbolDescriptionGene Name**1Hs.431048[NM_005157](ncbi-n:NM_005157){#ir0005}ABL1C-abl oncogene 1, receptor tyrosine kinaseABL/JTK72Hs.601206[NM_198889](ncbi-n:NM_198889){#ir0010}ANKRD17Ankyrin repeat domain 17GTAR/NY-BR-163Hs.73722[NM_080649](ncbi-n:NM_080649){#ir0015}APEX1APEX nuclease (multifunctional DNA repair enzyme) 1APE/APE-14Hs.367437[NM_000051](ncbi-n:NM_000051){#ir0020}ATMAtaxia telangiectasia mutatedAT1/ATA5Hs.271791[NM_001184](ncbi-n:NM_001184){#ir0025}ATRAtaxia telangiectasia and Rad3 relatedFRP1/MEC16Hs.533526[NM_000489](ncbi-n:NM_000489){#ir0030}ATRXAlpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae)ATR2/MRXHF17Hs.194143[NM_007294](ncbi-n:NM_007294){#ir0035}BRCA1Breast cancer 1, early onsetBRCAI/BRCC18Hs.519162[NM_006763](ncbi-n:NM_006763){#ir0040}BTG2BTG family, member 2PC3/TIS219Hs.292524[NM_001239](ncbi-n:NM_001239){#ir0045}CCNHCyclin HCAK/p3410Hs.184298[NM_001799](ncbi-n:NM_001799){#ir0050}CDK7Cyclin-dependent kinase 7CAK1/CDKN711Hs.24529[NM_001274](ncbi-n:NM_001274){#ir0055}CHEK1CHK1 checkpoint homolog (S. pombe)CHK112Hs.291363[NM_007194](ncbi-n:NM_007194){#ir0060}CHEK2CHK2 checkpoint homolog (S. pombe)CDS1/CHK213Hs.135471[NM_006384](ncbi-n:NM_006384){#ir0065}CIB1Calcium and integrin binding 1 (calmyrin)CIB/KIP14Hs.249129[NM_001279](ncbi-n:NM_001279){#ir0070}CIDEACell death-inducing DFFA-like effector aCIDE-A15Hs.151573[NM_004075](ncbi-n:NM_004075){#ir0075}CRY1Cryptochrome 1 (photolyase-like)PHLL116Hs.290758[NM_001923](ncbi-n:NM_001923){#ir0080}DDB1Damage-specific DNA binding protein 1, 127 kDaDDBA/UV-DDB117Hs.505777[NM_004083](ncbi-n:NM_004083){#ir0085}DDIT3DNA-damage-inducible transcript 3CEBPZ/CHOP18Hs.339396[NM_007068](ncbi-n:NM_007068){#ir0090}DMC1DMC1 dosage suppressor of mck1 homolog, meiosis-specific homologous recombination (yeast)DMC1H/HsLim1519Hs.435981[NM_001983](ncbi-n:NM_001983){#ir0095}ERCC1Excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)COFS4/UV2020Hs.487294[NM_000400](ncbi-n:NM_000400){#ir0100}ERCC2Excision repair cross-complementing rodent repair deficiency, complementation group 2 (xeroderma pigmentosum D)COFS2/EM921Hs.498248[NM_130398](ncbi-n:NM_130398){#ir0105}EXO1Exonuclease 1HEX1/hExoI22Hs.591084[NM_004629](ncbi-n:NM_004629){#ir0110}FANCGFanconi anemia, complementation group GFAG/XRCC923Hs.409065[NM_004111](ncbi-n:NM_004111){#ir0115}FEN1Flap structure-specific endonuclease 1FEN-1/MF124Hs.292493[NM_001469](ncbi-n:NM_001469){#ir0120}XRCC6X-ray repair complementing defective repair in Chinese hamster cells 6 (Ku autoantigen, 70 kDa)CTC75/CTCBF25Hs.80409[NM_001924](ncbi-n:NM_001924){#ir0125}GADD45AGrowth arrest and DNA-damage-inducible, alphaDDIT1/GADD4526Hs.9701[NM_006705](ncbi-n:NM_006705){#ir0130}GADD45GGrowth arrest and DNA-damage-inducible, gammaCR6/DDIT227Hs.661218[NM_002066](ncbi-n:NM_002066){#ir0135}GMLGlycosylphosphatidylinositol anchored molecule like proteinLY6DL28Hs.577202[NM_005316](ncbi-n:NM_005316){#ir0140}GTF2H1General transcription factor IIH, polypeptide 1, 62 kDaBTF2/TFIIH29Hs.191356[NM_001515](ncbi-n:NM_001515){#ir0145}GTF2H2General transcription factor IIH, polypeptide 2, 44 kDaBTF2/BTF2P4430Hs.386189[NM_016426](ncbi-n:NM_016426){#ir0150}GTSE1G-2 and S-phase expressed 1B9931Hs.152983[NM_004507](ncbi-n:NM_004507){#ir0155}HUS1HUS1 checkpoint homolog (*S. pombe*)Hus132Hs.503048[NM_002180](ncbi-n:NM_002180){#ir0160}IGHMBP2Immunoglobulin mu binding protein 2CATF1/HCSA33Hs.17253[NM_054111](ncbi-n:NM_054111){#ir0165}IHPK3Inositol hexaphosphate kinase 3INSP6K3/IP6K334Hs.61188[NM_033276](ncbi-n:NM_033276){#ir0170}XRCC6BP1XRCC6 binding protein 1KUB335Hs.1770[NM_000234](ncbi-n:NM_000234){#ir0175}LIG1Ligase I, DNA, ATP-dependentMGC11739736Hs.463978[NM_002758](ncbi-n:NM_002758){#ir0180}MAP2K6Mitogen-activated protein kinase kinase 6MAPKK6/MEK637Hs.432642[NM_002969](ncbi-n:NM_002969){#ir0185}MAPK12Mitogen-activated protein kinase 12ERK3/ERK638Hs.35947[NM_003925](ncbi-n:NM_003925){#ir0190}MBD4Methyl-CpG binding domain protein 4MED139Hs.195364[NM_000249](ncbi-n:NM_000249){#ir0195}MLH1MutL homolog 1, colon cancer, nonpolyposis type 2 (*E. coli*)COCA2/FCC240Hs.436650[NM_014381](ncbi-n:NM_014381){#ir0200}MLH3MutL homolog 3 (*E. coli*)HNPCC741Hs.509523[NM_002431](ncbi-n:NM_002431){#ir0205}MNAT1Menage a trois homolog 1, cyclin H assembly factor (*Xenopus laevis*)MAT1/RNF6642Hs.459596[NM_002434](ncbi-n:NM_002434){#ir0210}MPGN-methylpurine-DNA glycosylaseAAG/APNG43Hs.192649[NM_005590](ncbi-n:NM_005590){#ir0215}MRE11AMRE11 meiotic recombination 11 homolog A (*S. cerevisiae*)ATLD/HNGS144Hs.597656[NM_000251](ncbi-n:NM_000251){#ir0220}MSH2MutS homolog 2, colon cancer, nonpolyposis type 1 (*E. coli*)COCA1/FCC145Hs.280987[NM_002439](ncbi-n:NM_002439){#ir0225}MSH3MutS homolog 3 (*E. coli*)DUP/MRP146Hs.271353[NM_012222](ncbi-n:NM_012222){#ir0230}MUTYHMutY homolog (*E. coli*)MYH47Hs.396494[NM_018177](ncbi-n:NM_018177){#ir0235}N4BP2Nedd4 binding protein 2B3BP48Hs.492208[NM_002485](ncbi-n:NM_002485){#ir0240}NBNNibrinAT-V1/AT-V249Hs.66196[NM_002528](ncbi-n:NM_002528){#ir0245}NTHL1Nth endonuclease III-like 1 (*E. coli*)NTH1/OCTS350Hs.380271[NM_002542](ncbi-n:NM_002542){#ir0250}OGG18-oxoguanine DNA glycosylaseHMMH/HOGG151Hs.20930[NM_020418](ncbi-n:NM_020418){#ir0255}PCBP4Poly(rC) binding protein 4LIP4/MCG1052Hs.147433[NM_182649](ncbi-n:NM_182649){#ir0260}PCNAProliferating cell nuclear antigenMGC836753Hs.424932[NM_004208](ncbi-n:NM_004208){#ir0265}AIFM1Apoptosis-inducing factor, mitochondrion-associated, 1AIF/PDCD854Hs.111749[NM_000534](ncbi-n:NM_000534){#ir0270}PMS1PMS1 postmeiotic segregation increased 1 (*S. cerevisiae*)DKFZp781M0253/HNPCC355Hs.632637[NM_000535](ncbi-n:NM_000535){#ir0275}PMS2PMS2 postmeiotic segregation increased 2 (*S. cerevisiae*)HNPCC4/PMS2CL56Hs.225784[NM_005395](ncbi-n:NM_005395){#ir0280}PMS2L3Postmeiotic segregation increased 2-like 3PMS2L9/PMS557Hs.78016[NM_007254](ncbi-n:NM_007254){#ir0285}PNKPPolynucleotide kinase 3\'-phosphatasePNK58Hs.631593[NM_014330](ncbi-n:NM_014330){#ir0290}PPP1R15AProtein phosphatase 1, regulatory (inhibitor) subunit 15AGADD3459Hs.700597[NM_006904](ncbi-n:NM_006904){#ir0295}PRKDCProtein kinase, DNA-activated, catalytic polypeptideDNAPK/DNPK160Hs.531879[NM_002853](ncbi-n:NM_002853){#ir0300}RAD1RAD1 homolog (*S. pombe*)HRAD1/REC161Hs.16184[NM_002873](ncbi-n:NM_002873){#ir0305}RAD17RAD17 homolog (*S. pombe*)CCYC/HRAD1762Hs.375684[NM_020165](ncbi-n:NM_020165){#ir0310}RAD18RAD18 homolog (*S. cerevisiae*)RNF7363Hs.81848[NM_006265](ncbi-n:NM_006265){#ir0315}RAD21RAD21 homolog (*S. pombe*)HR21/HRAD2164Hs.655835[NM_005732](ncbi-n:NM_005732){#ir0320}RAD50RAD50 homolog (*S. cerevisiae*)RAD50-2/hRad5065Hs.631709[NM_002875](ncbi-n:NM_002875){#ir0325}RAD51RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae)BRCC5/HRAD5166Hs.172587[NM_133509](ncbi-n:NM_133509){#ir0330}RAD51L1RAD51-like 1 (*S. cerevisiae*)R51H2/RAD51B67Hs.655354[NM_004584](ncbi-n:NM_004584){#ir0335}RAD9ARAD9 homolog A (*S. pombe*)RAD968Hs.546282[NM_002894](ncbi-n:NM_002894){#ir0340}RBBP8Retinoblastoma binding protein 8CTIP/RIM69Hs.443077[NM_016316](ncbi-n:NM_016316){#ir0345}REV1REV1 homolog (*S. cerevisiae*)REV1L70Hs.461925[NM_002945](ncbi-n:NM_002945){#ir0350}RPA1Replication protein A1, 70 kDaHSSB/REPA171Hs.408846[NM_022367](ncbi-n:NM_022367){#ir0355}SEMA4ASema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4ACORD10/RP3572Hs.591336[NM_014454](ncbi-n:NM_014454){#ir0360}SESN1Sestrin 1PA26/SEST173Hs.211602[NM_006306](ncbi-n:NM_006306){#ir0365}SMC1AStructural maintenance of chromosomes 1ACDLS2/DKFZp686L1917874Hs.81424[NM_003352](ncbi-n:NM_003352){#ir0370}SUMO1SMT3 suppressor of mif two 3 homolog 1 (*S. cerevisiae*)DAP-1/GMP175Hs.654481[NM_000546](ncbi-n:NM_000546){#ir0375}TP53Tumor protein p53LFS1/TRP5376Hs.697294[NM_005427](ncbi-n:NM_005427){#ir0380}TP73Tumor protein p73P7377Hs.694840[NM_016381](ncbi-n:NM_016381){#ir0385}TREX1Three prime repair exonuclease 1AGS1/AGS578Hs.191334[NM_003362](ncbi-n:NM_003362){#ir0390}UNGUracil-DNA glycosylaseDGU/DKFZp781L114379Hs.654364[NM_000380](ncbi-n:NM_000380){#ir0395}XPAXeroderma pigmentosum, complementation group AXP1/XPAC80Hs.475538[NM_004628](ncbi-n:NM_004628){#ir0400}XPCXeroderma pigmentosum, complementation group CXP3/XPCC81Hs.98493[NM_006297](ncbi-n:NM_006297){#ir0405}XRCC1X-ray repair complementing defective repair in Chinese hamster cells 1RCC82Hs.647093[NM_005431](ncbi-n:NM_005431){#ir0410}XRCC2X-ray repair complementing defective repair in Chinese hamster cells 2DKFZp781P091983Hs.592325[NM_005432](ncbi-n:NM_005432){#ir0415}XRCC3X-ray repair complementing defective repair in Chinese hamster cells 3XRCC384Hs.444451[NM_016653](ncbi-n:NM_016653){#ir0420}ZAKSterile alpha motif and leucine zipper containing kinase AZKAZK/MLK7

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Instruments and reagents {#s0015}
-----------------------------

Agarose gels with normal and low melting points were purchased from the Biowest Company (Miami, FL, USA). Tris--HCl, DMSO, NaHCO3, formaldehyde (A.P.), trypan blue and TritonX-100 were purchased from Sigma (St. Louis, MO, USA). The electrophoresis apparatus was purchased from BIO-RAD (Hercules, CA, USA), and the Nikon90i fluorescence microscope was purchased from NIKON (Tokyo, Japan). The comet slides were purchased from Trevigen. Inc. (Gaithersburg, MD, USA).

2.2. Routine semen analysis {#s0020}
---------------------------

The procedure of routine semen analysis was performed according to the standard methods in the WHO manual [@bib2]. Briefly, the semen samples were examined immediately after liquefaction or within one hour of ejaculation. All the semen samples were ensured to be homogeneous by mixing thoroughly. A fixed volume of 10 μl semen was delivered onto a clean glass slide and covered with a coverslip. Scanning the slide and estimating the number of spermatozoa per 400× magnification field gives an approximate sperm concentration in 106/ml. This estimate is used to decide the dilution (1:5, 1:10, 1:20, 1:50) for determining the sperm concentration by hemocytometry. The spermatozoa concentration was determined using the hemocytometer method on two separate preparations of the semen sample. The diluted semen sample was dropped onto the hemocytometer and covered with a coverslip, and was placed in a humid chamber for about five minutes to prevent drying out. The cells sedimented during this time and were then counted. The count only included complete spermatozoa (heads with tails). Any sperm lying on the line dividing two adjacent squares was counted only if it was on the upper or the left side of the square being assessed.

2.3. Alkaline Comet assay {#s0025}
-------------------------

Spermatozoa or lymphocytes were suspended in PBS at a concentration of 1 × 105/ml. The comet assay, also called single cell gel electrophoresis, was performed as previously reported [@bib3]. Briefly, comet slides were coated with 100 μl of 0.75% (w/v) normal-melting-point agarose. Once the first agarose layer was coagulated, a mixture of 75 µl of low-melting-point agarose and 25 µl of spermatozoa suspension was applied as the second layer. The comet slides were immersed in cold lysis buffer (2.5 M NaCl, 0.5 M EDTA, 10 mM Tris HCl pH 10.0 containing 1% Triton X-100, 40 mM dithiothreitol and 100 μg/ml proteinase K) for 2 h at room temperature to remove any DNA-associated proteins. After lysis, double-distilled water was used to rinse away excess salt. All the comet slides were then placed in buffer for 20 min in a horizontal electrophoresis tank that was pre-filled with cold alkaline buffer (1 mM Na2EDTA and 0.3 M NaOH, pH 13.0) to loosen the tight double-helical structure of DNA for electrophoresis. Electrophoresis was then performed at 25 V and 10 mA for 20 min in electrophoresis buffer at room temperature. The slides were then rinsed twice with distilled water and stained with ethidium bromide (2 µg/ml). All of the above procedures were carried out in the dark to avoid additional DNA damage. The comets were viewed using a Nikon 90i fluorescence microscope, and images of 100 comets were collected for each subject using a digital imaging system. Cells that overlapped were not counted. All the comet images were analyzed using Comet Assay Software Project (CASP, Wroclaw University, Poland) [@bib4] and the DNA percentage in the comet tail (TDNA%), the tail moment (TM) and the Olive tail moment (OTM) were recorded to describe the DNA damage to the spermatozoa or lymphocytes.
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